Molecure (WAR:MOC) Total Assets: zł97.15 Mil (As of Sep. 2025)


WAR:MOC Molecure SA WAR:MOC
29 GF Score
Price zł6.04
! 3 Warning Signs
View Full Analysis

What is Molecure Total Assets?

Molecure WAR:MOC +3.78% 29 Total Assets is zł97.15 Mil as of Sep. 2025. GuruFocus rates WAR:MOC with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Molecure's Total Assets for the quarter that ended in Sep. 2025 was zł97.15 Mil.

During the past 12 months, Molecure's average Total Assets Growth Rate was 26.30% per year. During the past 3 years, the average Total Assets Growth Rate was 24.50% per year. During the past 5 years, the average Total Assets Growth Rate was 13.00% per year. During the past 10 years, the average Total Assets Growth Rate was 33.80% per year.

During the past 11 years, Molecure's highest 3-Year average Total Assets Growth Rate was 111.50%. The lowest was 9.60%. And the median was 22.10%.

Total Assets is connected with ROA %. Molecure's annualized ROA % for the quarter that ended in Sep. 2025 was -21.01%. Total Assets is also linked to Revenue through Asset Turnover. Molecure's Asset Turnover for the quarter that ended in Sep. 2025 was 0.00.

Molecure  (WAR:MOC) Total Assets Explanation

Total Assets is connected with ROA %.

Molecure's annualized ROA % for the quarter that ended in Sep. 2025 is

ROA %=Net Income (Q: Sep. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=-21.064/( (103.34+97.151)/ 2 )
=-21.064/100.2455
=-21.01 %

Note: The Net Income data used here is four times the quarterly (Sep. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Molecure's Asset Turnover for the quarter that ended in Sep. 2025 is

Asset Turnover
=Revenue (Q: Sep. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Sep. 2025 ))/ count )
=0/( (103.34+97.151)/ 2 )
=0/100.2455
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Molecure Total Assets Related Terms

Molecure Total Assets Historical Data

* Premium members only.

The historical data trend for Molecure's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecure Total Assets Chart

Molecure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 157.19 151.59 138.06 112.28 113.72

Molecure Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.71 113.72 107.45 103.34 97.15
WAR:MOC
29GF Score
Molecure SA WAR:MOC
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecure Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Molecure's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=103.408+10.314
=113.72

Molecure's Total Assets for the quarter that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (Q: Sep. 2025 )+Total Liabilities (Q: Sep. 2025 )
=89.426+7.725
=97.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of zł97.15 Mil mean?
Molecure (WAR:MOC) has a Total Assets of zł97.15 Mil as of Sep. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Molecure and its competitors.
Is Molecure's Total Assets too high?
Molecure's current Total Assets is zł97.15 Mil. Overall, Molecure has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Molecure's Total Assets compare to VRTX and REGN?
Molecure's Total Assets of zł97.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Molecure and its competitors. Molecure's current Total Assets is zł97.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecure stock overvalued right now?
Molecure (WAR:MOC) has a current Total Assets of zł97.15 Mil. The current Total Assets is zł97.15 Mil. Molecure's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Molecure (WAR:MOC), the current Total Assets is zł97.15 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecure Business Description

Other Exchanges 1B1:Germany
Address Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
29GF Score

Get the complete analysis for WAR:MOC

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł6.04
Price